Cargando…
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial
IMPORTANCE: Evidence of effective smoking cessation interventions in patients with diabetes is limited. The unique behavioral and metabolic characteristics of smokers with type 2 diabetes warrants a randomized clinical trial of the smoking cessation drug varenicline. OBJECTIVE: To evaluate the effic...
Autores principales: | Russo, Cristina, Walicka, Magdalena, Caponnetto, Pasquale, Cibella, Fabio, Maglia, Marilena, Alamo, Angela, Campagna, Davide, Frittitta, Lucia, Di Mauro, Maurizio, Caci, Grazia, Krysinski, Arkadiusz, Franek, Edward, Polosa, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214580/ https://www.ncbi.nlm.nih.gov/pubmed/35727580 http://dx.doi.org/10.1001/jamanetworkopen.2022.17709 |
Ejemplares similares
-
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol
por: Russo, C., et al.
Publicado: (2021) -
Efficacy of smoking cessation with varenicline plus counselling for e-cigarettes users (VAREVAPE): A protocol for a randomized controlled trial
por: Caponnetto, Pasquale, et al.
Publicado: (2019) -
Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes
por: Russo, Cristina, et al.
Publicado: (2016) -
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
por: Caponnetto, Pasquale, et al.
Publicado: (2023) -
Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users
por: Russo, Cristina, et al.
Publicado: (2018)